Quotations of 34 large-species collection pharmaceutical companies started

34 large varieties of Ganshan Union began to quote

01 Quotation from today

Recently, the "Notice on Doing a Good Job in the Online Quotation of Concentrated Drug Purchases in 2021 by the Gansu-Shaanxi Alliance" issued by the Gansu Provincial Public Resources Trading Center shows that from today (August 24), the alliance purchases involving 34 major varieties have begun to quote

According to the "Gansu-Shaanxi Alliance 2021 Drug Centralized Purchase Document" issued by the Gansu Provincial Public Resources Trading Center on July 23, the procurement involved 34 major varieties, most of which were injections, involving diabetes, hypertension, antibacterial, and antibacterial drugs.

The main body of this round of centralized procurement is still all public (including military) medical institutions in Gansu and Shaanxi Provinces, and medical insurance designated social medical institutions will be implemented in accordance with the requirements of designated agreement management

After reorganization, the data declaration time for this alliance procurement is from July 26th to August 5th.

The official document was released one month ago, and the quotation was made one month later.

02 Rules restrict price reduction

This selection rule adopts the classic "double envelope" model, in accordance with the principles of enterprise selection, product selection, and maintaining the stability of clinical drug use in the two provinces of the Gansu-Shaanxi Alliance, with reference to the two reference dimensions of economic and technical standards and commercial standards

Since local procurement with volume is still in the stage of separate exploration by provinces or inter-provincial alliances, there are certain differences in procurement rules in different regions

The evaluation criteria of business standards are mainly based on the quotation situation, with 30 points each for the absolute value of the quotation and the decrease of the quotation

The economic and technical target score is 40 points, and the evaluation dimensions are: market share, medical institution coverage, production company main income ranking, output ranking and supply capacity, quality bonus points, drug supervision quality random inspection, and integrity score assessment

The first four are good for large-scale companies.

From an overall point of view, since smaller companies do not have an advantage in economic and technological bids, they need to give lower quotations on commercial bids if they want to be selected

In addition to the selection criteria, the subsequent expert group bargaining rules also imposed strict restrictions on the price of medicines

According to the centralized procurement rules, the company's quotation shall not be higher than the current minimum bid-winning price of the company in the two provinces of Gansu and Shaanxi

If the number of declared companies is greater than or equal to 3, the company with the highest comprehensive score will be selected.

From the bidding regulations of 1.

03 Fierce price competition

The varieties purchased this time are all types of chemicals in the medical insurance drug catalog with high purchase amount, mature clinical use, strong substitutability, and sufficient market competition.

Taking troxerutin injection as an example, Cyberlan searched the database of the National Food and Drug Administration, and the search results showed that there were 96 approvals, and the variety appeared in the procurement catalogs of various levels for many times, and the price was reduced by a large margin
.
Taking the "six provinces and two districts" led by Sichuan Province at the beginning of this year, as an example, the quotation of troxerutin injection (2ml:0.
06g) circulating in the industry is 0.
13 yuan/piece
.

This time, the two provinces of the Gansu-Shaanxi Alliance have organized large-scale procurement for enterprises to participate in certain requirements
.

The document stipulates that companies that have not registered on the provincial drug procurement platforms of the two provinces of Gansu and Shaanxi shall be cancelled their qualifications; companies that have not registered on the provincial drug procurement platforms of the two provinces, in principle, It will not be accepted within 2 years to participate in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or to apply for the Sunshine website
.
In other words, for relevant companies, as long as they want to connect to the Internet in Gansu and Shaanxi provinces, they must participate in this centralized procurement
.

At that time, the 34 varieties of public medical institutions centered on the Ganshaan Alliance will face a new round of competition
.

The primary purpose of volume procurement is to reduce the gray space in drug prices to save medical insurance funds
.
In addition, whether it is the rules of volume procurement itself or the supporting policies for volume procurement, it involves many areas other than price, such as drug quality and clinical drug stability
.

Judging from the procurement rules of multiple inter-provincial alliances, companies that have passed product consistency evaluation and companies with a large market share may have certain advantages in the quotation process
.
For related companies, if they can give full play to their own advantages and win the bid at a more appropriate price, the company will also better balance the relationship between cost and the market
.

Attached: